Here’s a startling fact: nearly 12% of Americans live with diabetes, and almost 9% battle depression. While these numbers might seem disconnected, the reality is far more intertwined—and alarming. Did you know that having one of these conditions significantly increases your risk of developing the other? But here’s where it gets even more complicated: treating one condition can sometimes worsen the symptoms of the other, and many healthcare providers aren’t fully aware of this delicate balance. This is where pharmacists step in as unsung heroes, armed with the expertise to navigate this complex relationship and guide both patients and providers through the challenges.
At the ASHP Midyear 2025 conference, experts Kathleen M. Vest, PharmD, BCACP, CDCES, FCCP, and Sarah E. Grady, PharmD, BCPP, BCPS, shed light on how integrated, patient-centered care can break the vicious cycle of poor health tied to depression and diabetes. Their insights highlight the critical role pharmacists play in managing these comorbidities effectively.
Unraveling the Complex Link Between Diabetes and Depression
Chronic illnesses, like diabetes, often come with an unwelcome companion: depression. The stress of managing a lifelong condition, coupled with the side effects of medications, can trigger mental health struggles. And this is the part most people miss—individuals with diabetes are twice as likely to develop depression compared to those without it, according to Vest, a certified diabetes care and education specialist.
But the overlap doesn’t stop there. Depression’s symptoms can eerily mimic those of diabetes. Think of the mnemonic M SIG E CAPS:
- Mood (depressed)
- Sleep changes
- Interest (loss of, like anhedonia)
- Guilt or worthlessness
- Energy (decreased)
- Concentration (impaired)
- Appetite/weight changes
- Psychomotor agitation/retardation
- Suicidal ideation
A depression diagnosis requires at least five of these symptoms, with either depressed mood or anhedonia being one of them. Here’s the kicker: many diabetes patients experience symptoms like sleep changes, weight fluctuations, and fatigue as part of their condition. Vest notes, “Elevated blood sugars alone can drain energy and cloud concentration, making it hard to distinguish between diabetes and depression.”
Treatment Challenges: A Double-Edged Sword
Treating these comorbidities isn’t straightforward. Diabetes medications, particularly glucagon-like peptide-1 (GLP-1) drugs, can cause weight loss—a symptom often seen in depression. This overlap can muddy the waters for diagnosis and treatment. Conversely, antidepressants come with their own risks, like weight gain, increased appetite, and carbohydrate cravings, which can worsen diabetes control. Controversially, long-term antidepressant use has been linked to diabetes development, though it also reduces mortality in type 2 diabetes patients. Grady adds that substance use disorders, common in her behavioral health clinic, further complicate treatment, as antipsychotics and SSRIs can negatively impact glucose levels.
The Pharmacist’s Crucial Role
So, what’s the solution? Vest and Grady emphasize patient-centric care. Pharmacists should regularly screen diabetes patients for depression and vice versa, while monitoring how medications affect both conditions and quality of life. For instance, GLP-1 agonists, while effective for diabetes, can leave some patients feeling unwell. “Food is often a source of comfort for people with depression,” Vest explains, “and restricting it can worsen mood symptoms.”
Grady’s clinic takes a proactive approach, prescribing GLP-1 agonists alongside antipsychotics to counteract weight gain, but only after a thorough risk-benefit discussion with the patient. Here’s a thought-provoking question: Are we doing enough to break down silos in healthcare and ensure collaborative care across specialties? Grady believes integrating care is key to treating both conditions effectively.
Final Thoughts
The intersection of diabetes and depression is a complex, often overlooked challenge. Pharmacists, with their unique expertise, are perfectly positioned to bridge this gap. But what do you think? Is the healthcare system doing enough to address these comorbidities, or is there more work to be done? Share your thoughts in the comments below—let’s spark a conversation that could change lives.
Stay ahead of the curve in pharmacy practice—subscribe to Pharmacy Times for weekly clinical insights and updates.
